Drug Shortage Report for RABEPRAZOLE EC
| Report ID | 216283 |
| Drug Identification Number | 02356538 |
| Brand name | RABEPRAZOLE EC |
| Common or Proper name | RABEPRAZOLE EC |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-12 |
| Estimated end date | 2024-09-06 |
| Actual end date | 2024-09-04 |
| Shortage status | Resolved |
| Updated date | 2024-09-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2024-09-05 | English | Compare |
| v10 | 2024-09-04 | French | Compare |
| v9 | 2024-09-04 | English | Compare |
| v8 | 2024-08-21 | French | Compare |
| v7 | 2024-08-21 | English | Compare |
| v6 | 2024-05-28 | French | Compare |
| v5 | 2024-05-28 | English | Compare |
| v4 | 2024-01-30 | French | Compare |
| v3 | 2024-01-30 | English | Compare |
| v2 | 2024-01-17 | French | Compare |
| v1 | 2024-01-17 | English | Compare |
Showing 1 to 11 of 11